MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status
Published in
Acta neuropathologica, vol. 124, no. 4, p. 547-560Publication date
2012Abstract
Keywords
- Brain Neoplasms/classification/genetics
- CpG Islands
- DNA Methylation/genetics
- DNA Modification Methylases/genetics
- DNA Repair Enzymes/genetics
- Data Mining
- Gene Silencing
- Glioblastoma/classification/genetics
- High-Throughput Screening Assays
- Humans
- Logistic Models
- Models, Statistical
- Neoplasm Grading
- Oligonucleotide Array Sequence Analysis
- Phenotype
- Prognosis
- Promoter Regions, Genetic/genetics
- Tumor Suppressor Proteins/genetics
UNIGE affiliation entities
UNIGE research groups
Citation (ISO format)
BADY, Pierre et al. MGMT methylation analysis of glioblastoma on the Infinium methylation BeadChip identifies two distinct CpG regions associated with gene silencing and outcome, yielding a prediction model for comparisons across datasets, tumor grades, and CIMP-status. In: Acta neuropathologica, 2012, vol. 124, n° 4, p. 547–560. doi: 10.1007/s00401-012-1016-2
Main files (1)
Article (Published version)
Identifiers
- PID : unige:43567
- DOI : 10.1007/s00401-012-1016-2
- PMID : 22810491
